Alzheimer’s drug blocked by NHS ‘better than previously thought’
LONDON: Five-year findings suggest lecanemab’s benefits continue to grow, raising hopes patients could remain independent…
LONDON: Five-year findings suggest lecanemab’s benefits continue to grow, raising hopes patients could remain independent…